Perform Another (Advanced) Search

1.  Study Posting (77) Trial #130416, Systemic Lupus Erythematosus, Manhasset, NY
...been diagnosed with SLE • Biopsy with 6 month of screening visit indicating active proliferative lupus glomerulonephritis • Active renal disease at the screening visit You may not participate in this study if ...
View Page

2.  Study Posting (77) Trial #111143, Systemic Lupus Erythematosus, Lake Success, NY
...Have been diagnosed with SLE • Biopsy with 6 month screening visit indicating active proliferative lupus glomerulonephritis • Active renal disease at the screening visit You may not participate in this study if ...
View Page

3.  CenterWatch Clinical Research Profile (430) Trial #675, Radiant Research - Anderson, Anderson, SC
...Type II • Dialysis • Duodenal Ulcer • Female Sexual Dysfunction • Fibromyalgia • Gastric Irritation • GERD/Erosive Esophagitis • Glaucoma • Glomerulonephritis • Gout • Headache/Migraine • Herpes – Genital • Herpes – Zoster • Hormone Replacement Therapy • Hyperlipidemia • Hypertension • Incontinence • Indigestion • Influenza ...
View Page

4.  CenterWatch Clinical Research Profile (4802) Trial #1968, Capital Nephrology Medical Group, Sacramento, CA
...Experience Therapeutic Areas : • Anemia • Hypertension • Acute Renal Failure • Chronic Kidney Disease • Cardiovascular Diseases • Kidney Stones • Glomerulonephritis • Proteinuria • Parathyroidism/ Renal Osteodystrophy • Hemodialysis Vascular Access (Interventional Nephrology) Sponsors/CROs : • Amgen • Covance • Dynavax • Fibrogen ...
View Page

5.  Study Posting (4519) Trial #121654, Systemic Lupus Erythematosus, Bangkok, Thailand
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

6.  Study Posting (4519) Trial #121908, Systemic Lupus Erythematosus, Sevilla, Spain
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

7.  Study Posting (4519) Trial #121745, Systemic Lupus Erythematosus, Durban, South Africa
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

8.  Study Posting (4519) Trial #121491, Systemic Lupus Erythematosus, Cape Town, South Africa
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

9.  Study Posting (4519) Trial #121560, Systemic Lupus Erythematosus, Singapore, Singapore
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

10.  Study Posting (4519) Trial #121986, Systemic Lupus Erythematosus, Cebu City, Philippines
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

11.  Study Posting (4519) Trial #122053, Systemic Lupus Erythematosus, Kuching, Malaysia
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

12.  Study Posting (4519) Trial #148123, Systemic Lupus Erythematosus, Pécs, Hungary
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

13.  Study Posting (4519) Trial #121642, Systemic Lupus Erythematosus, Debrecen, Hungary
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

14.  Study Posting (4519) Trial #121481, Systemic Lupus Erythematosus, Budapest, Hungary
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

15.  Study Posting (4519) Trial #121536, Systemic Lupus Erythematosus, Strasbourg, France
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

16.  Study Posting (4519) Trial #121525, Systemic Lupus Erythematosus, Lille, France
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

17.  Study Posting (4519) Trial #121976, Systemic Lupus Erythematosus, Medellin, Colombia
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

18.  Study Posting (4519) Trial #121771, Systemic Lupus Erythematosus, Bogota, Colombia
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

19.  Study Posting (4519) Trial #121989, Systemic Lupus Erythematosus, Barranquilla, Colombia
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page

20.  Study Posting (4519) Trial #121470, Systemic Lupus Erythematosus, Vancouver, BC, Canada
...MMF or MTX for >=60 days prior to baseline. Exclusion Criteria: • active moderate to severe glomerulonephritis; • treatment with a second immunosuppressive or immunomodulatory drug in 8 weeks prior to baseline; • previous ...
View Page